Literature DB >> 30524493

Oculogyric Crisis with Downward Deviation - A Photo Essay.

Hüseyin Nezih Özdemir1, Neşe Çelebisoy1.   

Abstract

Oculogyric crisis (OGC) describes the clinical phenomenon of sustained dystonic, conjugate and typically upward deviation of the eyes. A few cases with downward or lateral deviations have been described.1,2.

Entities:  

Keywords:  Oculogyric crisis; downward; neuroleptics

Year:  2018        PMID： 30524493      PMCID： PMC6276947          DOI： 10.1080/01658107.2018.1424915

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN： 0165-8107


  6 in total

Review 1.  Treatment of movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

Review 2.  Oculogyric crises: Etiology, pathophysiology and therapeutic approaches.

Authors:  Ewgenia Barow; Susanne A Schneider; Kailash P Bhatia; Christos Ganos
Journal:  Parkinsonism Relat Disord       Date:  2016-11-23       Impact factor: 4.891

3.  Oculogyric crisis: a syndrome of thought disorder and ocular deviation.

Authors:  R J Leigh; J M Foley; B F Remler; R H Civil
Journal:  Ann Neurol       Date:  1987-07       Impact factor: 10.422

Review 4.  Acute and subacute drug-induced movement disorders.

Authors:  Pierre R Burkhard
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

5.  Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs.

Authors:  Susanne A Schneider; Vrajesh Udani; Charulata Sawant Sankhla; Kailash P Bhatia
Journal:  Mov Disord       Date:  2009-06-15       Impact factor: 10.338

6.  Acute dystonic reaction as medical emergency: a report of two cases.

Authors:  Ao Oyewole; Ao Adelufosi; O Abayomi
Journal:  Ann Med Health Sci Res       Date:  2013-07
  6 in total
  1 in total

1.  Oculogyric Crisis in a Girl with Infantile Parkinsonism-Dystonia-2.

Authors:  Bhanudeep Singanamalla; Gurpreet Kochar; Arushi Gahlot Saini
Journal:  Ann Indian Acad Neurol       Date:  2021-08-05       Impact factor: 1.383
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.